$204.9999
-13.3801[-6.13%]
At close: Apr 24
$204.9999
0[0.00%]
After Hours: 5:12PM EDT
Madrigal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Madrigal Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | MDGL | Q1 | -$4.23 | -$6.42 | — | — | $0.00 | — | — | — | Get Alert |
02/28/2024 | AM | MDGL | Q4 | -$4.98 | -$5.28 | -$5.68 | -7.58% | $0.00 | — | $0.00 | — | Get Alert |
11/06/2023 | AM | MDGL | Q3 | -$4.75 | -$4.92 | -$5.34 | -8.54% | $0.00 | — | $0.00 | — | Get Alert |
08/08/2023 | AM | MDGL | Q2 | -$4.14 | -$4.58 | -$4.69 | -2.40% | $0.00 | — | $0.00 | — | Get Alert |
05/09/2023 | AM | MDGL | Q1 | -$3.36 | -$4.94 | -$4.23 | 14.37% | $0.00 | — | $0.00 | — | Get Alert |
02/23/2023 | AM | MDGL | Q4 | -$3.78 | -$4.56 | -$4.98 | -9.21% | $0.00 | — | $0.00 | — | Get Alert |
11/03/2022 | AM | MDGL | Q3 | -$3.79 | -$4.15 | -$4.75 | -14.46% | $0.00 | — | $0.00 | — | Get Alert |
08/04/2022 | AM | MDGL | Q2 | -$3.72 | -$3.75 | -$4.14 | -10.40% | $0.00 | — | $0.00 | — | Get Alert |
05/09/2022 | AM | MDGL | Q1 | -$3.32 | -$3.62 | -$3.36 | 7.18% | $0.00 | — | $0.00 | — | Get Alert |
02/24/2022 | AM | MDGL | Q4 | -$3.82 | -$3.88 | -$3.78 | 2.58% | $0.00 | — | $0.00 | — | Get Alert |
11/04/2021 | AM | MDGL | Q3 | -$3.75 | -$3.90 | -$3.79 | 2.82% | $0.00 | — | $0.00 | — | Get Alert |
08/05/2021 | AM | MDGL | Q2 | -$3.18 | -$3.59 | -$3.72 | -3.62% | $0.00 | — | $0.00 | — | Get Alert |
05/06/2021 | AM | MDGL | Q1 | -$2.34 | -$3.85 | -$3.32 | 13.77% | $0.00 | — | $0.00 | — | Get Alert |
02/25/2021 | AM | MDGL | Q4 | -$1.80 | — | -$3.82 | — | $0.00 | — | $0.00 | — | Get Alert |
11/05/2020 | AM | MDGL | Q3 | -$1.39 | — | -$3.75 | — | $0.00 | — | $0.00 | — | Get Alert |
08/06/2020 | AM | MDGL | Q2 | -$1.28 | — | -$3.18 | — | $0.00 | — | $0.00 | — | Get Alert |
05/07/2020 | AM | MDGL | Q1 | -$0.98 | — | -$2.34 | — | $0.00 | — | $0.00 | — | Get Alert |
02/26/2020 | AM | MDGL | Q4 | — | — | -$1.80 | — | — | — | $0.00 | — | Get Alert |
11/06/2019 | AM | MDGL | Q3 | -$0.56 | — | -$1.39 | — | — | — | $0.00 | — | Get Alert |
Madrigal Pharmaceuticals (MDGL) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-5.68, which missed the estimate of $-5.28.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.